Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 10(a) of the Federal Advisory Committee Act, as amended, notice is hereby given of a meeting of the Novel and Exceptional Technology and Research Advisory Committee.

                    The meeting will be held as a virtual meeting and is open to the public. Individuals who plan to view the virtual meeting and need special assistance or other reasonable accommodations to view the meeting should notify the Contact Person listed below in advance of the meeting. The meeting will be videocast and can be accessed from the NIH Videocasting and Podcasting website (                    *http://videocast.nih.gov/​*).                

*Name of Committee:*                         Novel and Exceptional Technology and Research Advisory Committee.                    

*Date:*                         July 14, 2022.                    

*Time:*                         1:00 p.m. to 2:30 p.m.                    

*Agenda:*                         The Novel and Exceptional Technology and Research Advisory Committee meeting will include an update from the Working Group on Data Science and Emerging Technology and discussion of next steps regarding the current charge to the committee, delivered in June 2021.                    

*Place:*                         National Institutes of Health, 6705 Rockledge Drive, Suite 630, Bethesda, MD 20892 (Virtual Meeting Link will be available at                         *https://osp.od.nih.gov/​biotechnology/​main-nextrac/​#meetings*).                    

*Contact Person:*                         Jessica Tucker, Office of Science Policy, National Institutes of Health, 6705 Rockledge Drive, Suite 630, Bethesda, MD 20892, 301-496-9838,                         *SciencePolicy@od.nih.gov.*

                        Any interested person may file written comments by forwarding the statement to the Contact Person listed on this notice at least two business days prior to the meeting date. The statement should include the name, address, telephone number and, when applicable, the business or professional affiliation of the interested person. Other than name and contact information, please do not include any personally identifiable information or any information that you do not wish to make public. Proprietary, classified, confidential, or sensitive information should not be included in your comments. Please note that any written comments NIH receives may be posted                               ( print page 37521)                            unredacted to the Office of Science Policy website.                    

                        Information is also available on the NIH Office of Science Policy website:                         *https://osp.od.nih.gov/​biotechnology/​main-nextrac/​#meetings,*                         where an agenda, link to the webcast meeting, and any additional information for the meeting will be posted when available.                    

(Catalogue of Federal Domestic Assistance Program Nos. 93.14, Intramural Research Training Award; 93.22, Clinical Research Loan Repayment Program for Individuals from Disadvantaged Backgrounds; 93.232, Loan Repayment Program for Research Generally; 93.39, Academic Research Enhancement Award; 93.936, NIH Acquired Immunodeficiency Syndrome Research Loan Repayment Program; 93.187, Undergraduate Scholarship Program for Individuals from Disadvantaged Backgrounds, National Institutes of Health, HHS)

Dated: June 17, 2022.

Victoria Townsend,

Program Analyst, Office of Federal Advisory Committee Policy.

[FR Doc. 2022-13419 Filed 6-22-22; 8:45 am]

BILLING CODE 4140-01-P